Follow
Maj Schneider Thomsen
Maj Schneider Thomsen
Verified email at hst.aau.dk
Title
Cited by
Cited by
Year
The vascular basement membrane in the healthy and pathological brain
MS Thomsen, LJ Routhe, T Moos
Journal of Cerebral Blood Flow & Metabolism 37 (10), 3300-3317, 2017
3952017
Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo
KB Johnsen, M Bak, F Melander, MS Thomsen, A Burkhart, PJ Kempen, ...
Journal of Controlled Release 295, 237-249, 2019
1192019
Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles
KB Johnsen, M Bak, PJ Kempen, F Melander, A Burkhart, MS Thomsen, ...
Theranostics 8 (12), 3416, 2018
1092018
Targeted drug delivery to the brain using magnetic nanoparticles
LB Thomsen, MS Thomsen, T Moos
Therapeutic delivery 6 (10), 1145-1155, 2015
902015
Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood–brain barrier
MS Thomsen, S Birkelund, A Burkhart, A Stensballe, T Moos
Journal of neurochemistry 140 (5), 741-754, 2017
872017
Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons
MS Thomsen, MV Andersen, PR Christoffersen, MD Jensen, J Lichota, ...
Neurobiology of Disease 81, 108-118, 2015
872015
Transfection of brain capillary endothelial cells in primary culture with defined blood–brain barrier properties
A Burkhart, LB Thomsen, MS Thomsen, J Lichota, C Fazakas, I Krizbai, ...
Fluids and Barriers of the CNS 12, 1-14, 2015
472015
The blood-brain barrier studied in vitro across species
MS Thomsen, N Humle, E Hede, T Moos, A Burkhart, LB Thomsen
PLoS One 16 (3), e0236770, 2021
322021
Blood–Brain barrier transport of transferrin Receptor-Targeted nanoparticles
MS Thomsen, KB Johnsen, K Kucharz, M Lauritzen, T Moos
Pharmaceutics 14 (10), 2237, 2022
212022
Accessing targeted nanoparticles to the brain: The vascular route
A Burkhart, M Azizi, MS Thomsen, LB Thomsen, T Moos
Current medicinal chemistry 21 (36), 4092-4099, 2014
152014
Astrocytic expression of ZIP14 (SLC39A14) is part of the inflammatory reaction in chronic neurodegeneration with iron overload
LJ Routhe, IK Andersen, LV Hauerslev, II Issa, T Moos, MS Thomsen
Glia 68 (9), 1810-1823, 2020
102020
Sortilin regulates blood–brain barrier integrity
AE Toth, HC Helms, A Harazin, KB Johnsen, C Goldeman, A Burkhart, ...
The FEBS Journal 289 (4), 1062-1079, 2022
92022
Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles. Theranostics. 2018; 8 (12): 3416–36
KB Johnsen, M Bak, PJ Kempen, F Melander, A Burkhart, MS Thomsen, ...
Epub 2018/06/23. https://doi. org/10.7150/thno. 25228 PMID: 29930740, 0
6
Mutation of tyrosine sites in the human alpha-synuclein gene induces neurotoxicity in transgenic mice with soluble alpha-synuclein oligomer formation
LB Lassen, MS Thomsen, E Basso, EM Füchtbauer, A Füchtbauer, ...
Cells 11 (22), 3673, 2022
42022
The significance of the choroid plexus for cerebral iron homeostasis
LJ Routhe, MS Thomsen, T Moos
Role of the Choroid Plexus in Health and Disease, 125-148, 2020
32020
Expression and deposition of basement membrane proteins by brain capillary endothelial cells in a primary murine model of the blood-brain barrier
MS Thomsen, S Birkelund, AB Larsen, A Stensballe, T Moos
Final Programme, 19th International Symposium on Signal Transduction at the …, 2016
12016
Protective and toxic proteins in Alzheimer’s disease
MS Thomsen
MSc Thesis, 2012
12012
Potential Retinal Biomarkers in Alzheimer’s Disease
MY García-Bermúdez, R Vohra, K Freude, P Wijngaarden, K Martin, ...
International Journal of Molecular Sciences 24 (21), 15834, 2023
2023
Significant change in biometal distribution in brains of Alzheimer´ s Disease (TgSwDI) mice
MS Thomsen, T Moos, SG Echers, AH Nielsen, N Ganesalingam
International Conference on Alzheimer’s and Parkinson’s Diseases and related …, 2023
2023
A novel bispecific antibody able to pass the blood-brain barrier and therapeutically engage within the brain
MS Thomsen, T Moos
Med 3 (12), 815-817, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20